<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89096">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01986452</url>
  </required_header>
  <id_info>
    <org_study_id>StrOSA2013</org_study_id>
    <nct_id>NCT01986452</nct_id>
  </id_info>
  <brief_title>Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA</brief_title>
  <official_title>CPAP Therapie Mit Telemonitoring Bei Obstruktiver Schlafapnoe Und Apoplexie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pneumologie Hagen Ambrock eV</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Reinhard Löwenstein-Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut für Pneumologie Hagen Ambrock eV</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Apoplexy patients with OSA are often not receiving a CPAP therapy due to generally poor
      acceptance and adherence. There is a great potential to significantly improve the treatment
      and care of these patients in a time economic way by telemonitoring the therapy in home
      environment.

      This study is planned to prove that telephone consultancy and motivation in times of
      recorded decreasing CPAP therapy usage can improve adherence, neurological function and
      quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients with confirmed OSA from neurological rehab department of Helios Clinic
      Hagen Ambrock are asked to join the study. They will be randomly assigned to one of two arms
      [CPAP with Telemonitoring (MTM) or without Telemonitoring (OTM)] for 6 months of home
      treatment after hospital discharge.  The MTM arm will receive supporting phone calls when
      the monitored usage time decreases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Adherence to CPAP usage</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>CPAP device usage time will be readout and compared.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients will fill the questionnaire SF-12 Health Survey  before starting the therapy and after 6 months of therapy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>OSA</condition>
  <condition>Apoplexy</condition>
  <arm_group>
    <arm_group_label>Unattended CPAP therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapy data will be examined by reading out the CPAP device after 6 months.  Patients can obtain help on own request, corresponding to the standard CPAP prescription routine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemonitoring and support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP device therapy data will be downloaded by the study site via GSM modules once a week. In case of poor therapy adherence (defined by a minimum average usage of 3h/night over the week) a contact call will be initiated to motivate patients or solve problems identified by telemonitoring. If active home intervention is required, the study site will inform the healthcare provider to visit the patient in a timely manner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP therapy</intervention_name>
    <arm_group_label>Unattended CPAP therapy</arm_group_label>
    <arm_group_label>Telemonitoring and support</arm_group_label>
    <other_name>ICON™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Support</intervention_name>
    <arm_group_label>Telemonitoring and support</arm_group_label>
    <other_name>Motivation</other_name>
    <other_name>Telemonitoring</other_name>
    <other_name>Software Infosmart Web</other_name>
    <other_name>GSM module</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  s/p ACM (Arteria Cerebri Media Insult)

          -  Diagnosed OSA AHI &gt;15/h

          -  Barthel Index item 8 &gt; 5 points (or home assistance)

          -  Life expectancy &gt;6 month

          -  Capable of giving consent

        Exclusion Criteria:

          -  Already existing ventilatory support (CPAP, NIV etc)

          -  Central AI &gt;50% baseline

          -  Central AI &gt;5/h under CPAP therapy

          -  Drug abuse

          -  Pregnant or nursing women

          -  Participation in another clinical trial last 4 weeks
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Nilius, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Klinik Hagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georg Nilius, MD</last_name>
    <phone>0049 2331 974</phone>
    <phone_ext>2000</phone_ext>
    <email>georg.nilius@helios-kliniken.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrike Domanski</last_name>
    <phone>0049 2331 974</phone>
    <phone_ext>2080</phone_ext>
    <email>ulrike.domanski@helios-kliniken.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helios Klinik Hagen</name>
      <address>
        <city>Hagen</city>
        <state>NRW</state>
        <zip>58091</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nilius, MD</last_name>
      <phone>0049 2331 974</phone>
      <phone_ext>2000</phone_ext>
      <email>georg.nilius@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Karl Heinz Rühle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>November 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut für Pneumologie Hagen Ambrock eV</investigator_affiliation>
    <investigator_full_name>Georg Nilius</investigator_full_name>
    <investigator_title>Head of Pneumology Department of Helios Clinic Hagen</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>Apoplexy</keyword>
  <keyword>CPAP</keyword>
  <keyword>adherence</keyword>
  <keyword>telemonitoring</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
